ภาควิชากุมารเวชศาสตร์ | คณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล

1.

Musallam KM, Sheth S, Cappellini MD, Shah F, Rivella S, Sankaran VG, Kuo KHM, Viprakasit V, Eleftheriou A, Angastiniotis M, Locatelli F, Taher AT.

Management of transfusion-dependent ?-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources
The Lancet Haematology. 2026. 13 (1): e49-e54.

2.

Viprakasit V, Tulalamba W, Suksangpleng T, Ekwattanakit S.

Thailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential
Clinical and translational science. 2026. 19 (4):

3.

Pratumkaew P, Wattanapanitch M, Viprakasit V, Kheolamai P, Issaragrisil S.

Induced pluripotent stem cell-based modeling of hemolytic anemia in patients with compound heterozygous KLF1 mutations reveals defective erythroid differentiation
Stem Cell Res Ther. 2026. 17 (1):

4.

Vlachodimitropoulou E, Baldini M, Al-Samkari H, Cappellini MD, Coates TD, Kuo KHM, Sheth S, Taher AT, Viprakasit V, Musallam KM.

Addressing Obstetric and Gynecologic Needs in Thalassemia
O G Open. 2026. 3 (4):

5.

Cappellini M.D.; Sheth S.; Taher A.; Al-Samkari H.; Antmen A.B.; Beneitez Pastor D.; Cannas G.; Coates T.; Czapla L.; Dahlin J.L.; Estepp J.H.; Feenstra E.; Georgiev P.; Gheuens S.; Price G.M.; Glenth?j A.; Musallam K.M.; Osman K.; Porter J.B.; Shao H.; Uhlig K.; van Beers E.J.; Viprakasit V.; Kuo K.H.M.; Kattamis A.; Cassinerio E.; Maira D.; Graziadei G.; Motta I.; Migone De Amicis M.; Scaramellini N.; Romana Giuditta M.; Ferrero G.B.; Bisaccia A.; Gaglioti C.M.; Mandrile G.; Lauria S.; Ceglie T.; Voi V.; Origa R.; Denotti A.R.; Zaccheddu E.; Barella S.; Longo F.; Mari E.; Sofritti O.; Ferrara F.; Ricci A.; Farina F.M.; Pastore D.; Pasanisi A.; Solfrizzi M.P.; Taher A.; Machmouchi A.; Klim J.; Sharrouf L.; Akiki N.; Koussa S.; Younes W.; Kori A.N.; Amir Khalid N.A.; Nordin N.; Abdul Wahab S.; Aun E.S.-Y.; Leong T.S.; Chew L.P.; Chieng G.L.W.; Tiong X.T.; Liew H.K.; Wong C.H.; Aziz N.A.; Liam C.C.K.; Lim S.M.; Sharif A.; Wong Y.S.; Wong L.L.L.; Wilfred G.; Choo H.C.; Sivakumar K.; Bin Ahmad Zakhi M.T.; Lim Y.M.; Muda Z.B.; Gunasagaran K.; Bin Unni M.N.; Hong S.Y.; Goh A.S.; Goh C.C.Y.; Chew T.K.; Chieng S.K.; Lee K.T.; Tan S.K.; Selvaratnam V.; Raghunathan K.; Tanusha K.; Yap (Yee Yee) M.; Ramli R.; Nasution S.F.; van Beers E.; Derichs C.; Saes J.; van der Zwet K.; Rijneveld A.; Kruip M.J.H.A.; Biemond B.J.; Nur E.; Alanazi N.; Al Garni A.; Al Shuaibi M.; Algahtani F.; Al Raizah A.; Al Garni A.; Alaskar A.; Hejazi A.; Alzahrani M.; Payan-Pernia S.; Mignot Castellano E.; Jim?nez Jambrina M.; Morado Arias M.; Garc?a P?rez E.; Canales Albendea M.A.; Cabirta Touz?n A.; Puyuelo Benito A.; Ortu?o Cabrera A.; Serna Pareja ?.; Garc?a Herce C.; Fern?ndez Camacho I.; Hidalgo Soto M.; Garrido Paniagua S.; Salido Fi?rrez E.J.; Cascales Hern?ndez A.; Moreno Belmonte M.J.; Sanchez Villalobos M.; P?rez L?pez R.; Caba?as Perianes V.; Wang S.-C.; Lai K.-M.; Wang W.-H.; Peng C.-T.; Su M.-Y.; Lu M.-Y.; Chang H.-H.; Peng S.-F.; Chou S.-W.; Shih T.-F.; Yang Y.-L.; Viprakasit V.; Khiewvan B.; Buaboonnam J.; Ekwattanakit S.; Paiboonsukwong K.; Faknuam S.; Fucharoen S.; Tantiworawit A.; Chai-Adisaksopha C.; Rattarittamrong E.; Norasetthada L.; Piriyakhuntorn P.; Hantrakool S.; Wong P.; Tapprom A.; Kittijarukhajorn M.; Chumnumsiriwath P.; Deoisares R.; Uaprasert N.; Chanswangphuwana C.; Moonla C.; Rojnuckarin P.; Hongeng S.; Chuansumrit A.; Songdej D.; Sirachainan N.; Teawtrakul N.; Wanitpongpun C.; Chansung K.; Phiphitaporn P.; Lanamtieng T.; Numbenjapon T.; Lamool R.; Aydinok Y.; Karadas N.; Unal Cangul S.; Gumruk F.; Hazirolan T.; Leblebisatan G.; Ozkan A.; Kupesiz O.A.; Kupesiz F.T.; Erkan M.; Ozturk Z.; Sasmaz H.I.; Karakas Z.; Tanyildiz H.G.; Karaman S.; Sahin S.; Yilmaz Y.; Aykyol Sari Z.N.; Musallam K.; Alrustamani A.; George B.; Alhaj M.; Kaloyannidis P.; Layton D.M.; Luqmani A.; Sohal M.; Okoli S.; Porter J.; Garbowski M.; Eleftheriou P.; Al-Samkari H.; Kuter D.; Smith D.; Goodarzi K.; Bornikova L.; Pereira L.; Hodges P.; Rosovsky R.; Jundzil T.; Wood V.; Strouse J.J.; Shah N.R.; Adam S.; Sheth S.; Mensah C.; Kleinert D.; Chien M.; Chien C.L.; Esrick E.; Eile J.; Lal A.; Rishon A.; Vissa M.; Fertrin K.Y.; Scott B.; Enslin L.; Linenberger M.; Kang N.; Portillo S.; Keel S.; Shah S.; Olson B.; Knoll C.; Gomez E.; Swartz K.; Quarmyne M.-O.; Mis N.; Badia Alonso P.; White S.; Gopal S.; Von Drygalski A.; Nguyen A.; Sacknoff S.; Sayani F.; Russell J.E.; Peslak S.; Glaros A.; Meinke S.; Babin V.

Efficacy and safety of mitapivat in adults with transfusion-dependent ?-thalassaemia or ?-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
The Lancet. 2026. 408 (10559): 1010-1018.

6.

Taron W.; Kasemphong T.; Sunon P.; Kaewket K.; Kamonsutthipaijit N.; Ketudat-Cairns J.R.; Bhakdisongkhram G.; Tulalamba W.; Sanguansuk S.; Viprakasit V.; Ngamchuea K.

Bioanalytical method for NAD+ detection in blood plasma utilizing solution-phase Candida boidinii formate dehydrogenase and electrochemical detection
Analyst. 2025.

7.

Musallam K.M.; Sheth S.; Coates T.D.; Al-Samkari H.; Cappellini M.D.; Kuo K.H.M.; Viprakasit V.; Taher A.T.

Non-Transfusion-Dependent Thalassemia: An Image Gallery Worth a Thousand Words
American Journal of Hematology. 2025. 100 (4): 687-694.

8.

Cappellini M.D.; Viprakasit V.; Georgiev P.; Coates T.D.; Origa R.; Khelif A.; Liew H.-K.; Tantiworawit A.; Chew L.-P.; Khalil A.; Ho P.J.; Kuo K.H.M.; Holot N.; Perin M.; Giuseppi A.C.; Kuo W.-L.; Lai Y.; Medlin L.F.; Bueno L.M.; Kattamis A.; Taher A.T.

Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial
The Lancet Haematology. 2025. 12 (3): e180-e189.

9.

Taher AT, Al-Samkari H, Aydinok Y, Besser M, Boscoe AN, Dahlin JL, De Luna G, Estepp JH, Gheuens S, Gilroy KS, Glenthøj A, Sim Goh A, Iyer V, Kattamis A, Loggetto SR, Morris S, Musallam KM, Osman K, Ricchi P, Salido-Fiérrez E, Sheth S, Tai F, Tevich H, Uhlig K, Urbstonaitis R, Viprakasit V, Cappellini MD, Kuo KHM; ENERGIZE investigators.

Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial
Lancet. 2025. 406 (10498): 33-42.

10.

Taher AT, Viprakasit V, Kattamis A Prof, Perrotta S, Ricchi P, Porter JB, Coates TD, Forni GL, Musallam KM, Esposito O, Pilot R, Kuo WL, Lai Y, Reverte M, Wei R, Moro Bueno L, Cappellini MDD.

Efficacy and safety of luspatercept in non-transfusion-dependent ?-thalassemia: long-term results from the BEYOND study
Blood Adv. 2025.

ผลงานที่ได้รับการตีพิมพ์

ศ.ดร.นพ. วิปร วิประกษิต